1,271
Views
4
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR: CLINICAL ONCOLOGY

Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation

ORCID Icon, , , , , , , & show all
Pages 496-499 | Received 05 Oct 2021, Accepted 29 Dec 2021, Published online: 11 Jan 2022

References

  • Engert A, Plütschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med. 2010;363(7):640–652.
  • André MPE, Girinsky T, Federico M, et al. Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol. 2017;35(16):1786–1794.
  • Jaworski C, Mariani JA, Wheeler G, et al. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61(23):2319–2328.
  • Adams MJ, Lipshultz SE, Schwartz C, et al. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol. 2003;13(3):346–356.
  • Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol. 2004;22(15):3139–3148.
  • Loap P, Servois V, Dhonneur G, et al. A radiotherapy contouring atlas for cardiac conduction node delineation. Pract Radiat Oncol. 2021;11(4):e434–e437.
  • Filippi AR, Meregalli S, DI Russo A, Fondazione Italiana Linfomi (FIL) Radiotherapy Committee, et al. Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum. Radiat Oncol. 2020;15(1):62.
  • Specht L, Yahalom J, Illidge T, ILROG, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2014;89(4):854–862.
  • Qiu J, Liu Z, Yang B, et al. Low-dose-area-constrained helical tomotherapy-based whole breast radiotherapy and dosimetric comparison with tangential field-in-Field IMRT [Internet]. Biomed Res Int. 2013;2013:513708.
  • Loap P, De Marzi L, Mirandola A, et al. Development and implementation of proton therapy for Hodgkin lymphoma: challenges and perspectives. Cancers. 2021;13(15):3744.
  • Loap P, Mirandola A, De Marzi L, et al. Current situation of proton therapy for Hodgkin lymphoma: from expectations to evidence. Cancers. 2021;13(15):3746.
  • Dabaja BS, Hoppe BS, Plastaras JP, et al. Proton therapy for adults with mediastinal lymphomas: the international lymphoma radiation oncology group guidelines. Blood. 2018;132(16):1635–1646.
  • Mirandola A, Molinelli S, Vilches Freixas G, et al. Dosimetric commissioning and quality assurance of scanned ion beams at the Italian National Center for oncological hadrontherapy. Med Phys. 2015;42(9):5287–5300.
  • Hoppe BS, Bates JE, Mendenhall NP, et al. The meaningless meaning of mean heart dose in mediastinal lymphoma in the modern radiation therapy era. Pract Radiat Oncol. 2019;10(3):e147–e154.
  • Atkins KM, Chaunzwa TL, Lamba N, et al. Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer. JAMA Oncol. 2021;7(2):206–219.
  • Loap P, Tkatchenko N, Nicolas E, et al. Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2020;153:146–154.
  • Duane F, Aznar MC, Bartlett F, et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol. 2017;122(3):416–422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.